MODULATION OF ANTIVIRAL IMMUNE-RESPONSES BY EXOGENOUS CYTOKINES - EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-ALPHA, INTERLEUKIN-2 AND INTERFERON-GAMMA ON THE IMMUNOGENICITY OF AN INACTIVATED RABIES VACCINE

被引:47
作者
SCHIJNS, VECJ
CLAASSEN, IJTM
VERMEULEN, AA
HORZINEK, MC
OSTERHAUS, ADME
机构
[1] UNIV UTRECHT, FAC VET, INST VIROL, DEPT INFECT DIS & IMMUNOL, 3508 TD UTRECHT, NETHERLANDS
[2] NATL INST PUBL HLTH & ENVIRONM PROTECT, 3720 BA BILTHOVEN, NETHERLANDS
[3] ERASMUS UNIV ROTTERDAM, FAC MED, DEPT VIROL, 3000 DR ROTTERDAM, NETHERLANDS
关键词
D O I
10.1099/0022-1317-75-1-55
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In vivo administration of exogenous cytokines may influence elicited immune responses, and hence may change the efficacy of a vaccine. We investigated the effects of tumour necrosis factor-alpha (TNF-alpha), interleukin-1 alpha (IL-1 alpha), interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) on the immune response elicited by inactivated rabies virus vaccine in a mouse model. Each of the cytokines increased virus-specific IgG responses after primary and after secondary immunization. A single dose of 1.3 ng TNF-alpha or IL-1 alpha, when injected shortly before vaccination, only marginally stimulated resistance to challenge infection (four- and seven-fold, respectively) without enhancing virus neutralizing antibody (VNAb) responses. In contrast, a single injection of 10(3) units of IFN-gamma or five daily injections of 1.6 mu g IL-2 increased vaccine dilutions protecting 50 % of mice (PD50 values) 77- to 50-fold, respectively, with a concomitant enhancement of VNAb. At a 1:10000 dilution of a standard inactivated rabies vaccine preparation both IFN-gamma and IL-2 increased protective immunity without enhancing VNAb responses; in non-vaccinated animals this treatment had no effect on resistance to challenge. Combined administration of IFN-gamma, and IL-2 synergistically enhanced VNAb responses. In contrast to the other cytokines tested, IFN-gamma preferentially stimulated virus-specific IgG2a production. It also augmented the vaccine-induced priming of rabies virus-specific splenocyte proliferation. These results document that certain cytokines alone or in combination are potent immunological adjuvants which may direct and modulate immunization-induced antiviral immune responses.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 48 条
[1]   SUCCESSFUL PROPHYLAXIS AGAINST RABIES IN MICE AND RHESUS-MONKEYS - INTERFERON SYSTEM AND VACCINE [J].
BAER, GM ;
SHADDOCK, JH ;
MOORE, SA ;
YAGER, PA ;
BARON, SS ;
LEVY, HB .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (02) :286-291
[2]   INDUCTION, INVIVO AND INVITRO, OF MACROPHAGE MEMBRANE INTERLEUKIN-1 BY ADJUVANT-ACTIVE SYNTHETIC MURAMYL PEPTIDES [J].
BAHR, GM ;
CHEDID, LA ;
BEHBEHANI, K .
CELLULAR IMMUNOLOGY, 1987, 107 (02) :443-454
[3]   IFN-GAMMA ENHANCES SECRETION OF IGG2A FROM IGG2A-COMMITTED LPS-STIMULATED MURINE B-CELLS - IMPLICATIONS FOR THE ROLE OF IFN-GAMMA IN CLASS SWITCHING [J].
BOSSIE, A ;
VITETTA, ES .
CELLULAR IMMUNOLOGY, 1991, 135 (01) :95-104
[4]   INTRACEREBRAL INOCULATION OF MICE - FATE OF THE INOCULUM [J].
CAIRNS, HJF .
NATURE, 1950, 166 (4230) :910-911
[5]   DIFFERENTIAL ACTIVATION OF CYTOKINE GENES IN NORMAL CD4-BEARING T-CELLS IS STIMULUS DEPENDENT [J].
CARDING, SR ;
WEST, J ;
WOODS, A ;
BOTTOMLY, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (02) :231-238
[6]  
CELIS E, 1986, J IMMUNOL, V136, P692
[7]   REGULATION OF MURINE LYMPHOKINE PRODUCTION INVIVO .3. THE LYMPHOID-TISSUE MICROENVIRONMENT EXERTS REGULATORY INFLUENCES OVER T-HELPER CELL-FUNCTION [J].
DAYNES, RA ;
ARANEO, BA ;
DOWELL, TA ;
HUANG, K ;
DUDLEY, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) :979-996
[8]   DELINEATION OF PUTATIVE MECHANISMS INVOLVED IN ANTIBODY-MEDIATED CLEARANCE OF RABIES VIRUS FROM THE CENTRAL-NERVOUS-SYSTEM [J].
DIETZSCHOLD, B ;
KAO, M ;
ZHENG, YM ;
CHEN, ZY ;
MAUL, G ;
FU, ZF ;
RUPPRECHT, CE ;
KOPROWSKI, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :7252-7256
[9]   INDUCTION OF RABIES VIRUS-SPECIFIC T-HELPER CELLS BY SYNTHETIC PEPTIDES THAT CARRY DOMINANT T-HELPER CELL EPITOPES OF THE VIRAL RIBONUCLEOPROTEIN [J].
ERTL, HCJ ;
DIETZSCHOLD, B ;
GORE, M ;
OTVOS, L ;
LARSON, JK ;
WUNNER, WH ;
KOPROWSKI, H .
JOURNAL OF VIROLOGY, 1989, 63 (07) :2885-2892
[10]  
FINKELMAN FD, 1988, J IMMUNOL, V140, P1022